A- A A+

Treatment of opioid dependence with buprenorphine: current update.

Soyka M.

Dialogues Clin Neurosci. 2017 Sep;19(3):299-308.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741113/

Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers.

Butler SF, Black RA, Severtson SG, Dart RC, Green JL.

J Subst Abuse Treat. 2018 Jan;84:42-49. doi: 10.1016/j.jsat.2017.10.010.

http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30354-9/fulltext

Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.

Lugoboni F, Zamboni L, Federico A, Tamburin S, for the Gruppo InterSERT di Collaborazione Scientifica (GICS) (2017)

PLoS ONE 12(11): e0188994. doi.org/10.1371/journal.pone.0188994

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188994

Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update).

Alderks CE.

The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-.

https://www.ncbi.nlm.nih.gov/books/NBK469748/

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.

Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M.

Expert Opin Pharmacother. 2017 Dec 3:1-13. doi: 10.1080/14656566.2017.1409722.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29183228

Indien. Drug to treat heroin habit most abused

CHANDIGARH: Going by seizures of narcotics and psychotropic substances in Chandigarh this year, buprenorphine — a banned injectable drug used for treating heroin addiction — has emerged as the most used illegal substance in the city, with an average of more than 10 vials of the pharmaceutical drug being recovered each day. (Times of India, 01.01.2018)

https://timesofindia.indiatimes.com/city/chandigarh/drug-to-treat-heroin-habit-most-abused/articleshow/62322161.cms

Traditional Chinese medicine-facilitated treatments may relieve anxiety symptoms during drug switching from methadone to buprenorphine/naloxone for treating opioid dependence.

Yu KC, Wei HT, Yeh YH, Hsu CH.

BMJ Case Rep. 2017 Nov 9;2017. pii: bcr-2017-220815. doi: 10.1136/bcr-2017-220815.

http://casereports.bmj.com/content/2017/bcr-2017-220815.long

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.

Chavan NR, Ashford KB, Wiggins AT, Lofwall MR, Critchfield AS.

AJP Rep. 2017 Oct;7(4):e215-e222. doi: 10.1055/s-0037-1608783.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720890/

Opiatentzug: Naltrexon und Buprenorphin in Studie gleich gut wirksam

New York – Die Opioidkrise, die von der US-Regierung jetzt zu einem nationalen Notstand erklärt wurde, wird die Behandlung Hunderttausender Abhängiger erforderlich machen. Das National Institute on Drug Abuse hat in einer randomisierten klinischen Studie zwei mögliche Therapien prüfen lassen – mit vergleichbaren Ergebnissen, wie die Publikation im Lancet (2017; doi: 10.1016/S0140-6736(17)32812-X) zeigt. (aerzteblatt.de, 17.11.2017)

https://www.aerzteblatt.de/nachrichten/83509/Opiatentzug-Naltrexon-und-Buprenorphin-in-Studie-gleich-gut-wirksam

Opioid Withdrawal Presenting as Delirium and Role of Buprenorphine: A Case Series.

Das S, Sah D, Nandi S, Das P.

Indian J Psychol Med. 2017 Sep-Oct;39(5):665-667. doi: 10.4103/0253-7176.217027.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688897/

USA. FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

Agency encourages safe adoption and more widespread use of FDA-approved treatments to help combat opioid addiction

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder. (FDA, 30.11.2017)

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587312.htm

Second Injectable Buprenorphine Product Shows Promise

SAN DIEGO, California ― An injectable, subcutaneous form of buprenorphine (CAM2038, Braeburn Pharmaceuticals) demonstrated noninferiority to sublingual buprenorphine tablets for opioid use disorder (OUD) in new research findings.

Results of a randomized phase 3 efficacy and safety trial show that the drug, which can be administered weekly or monthly, may be a second injectable option for improving adherence and reducing misuse of the drug. (Medscape, 21.12.2017)

https://www.medscape.com/viewarticle/890463

Ultrarapid Influence of Buprenorphine on Major Depression in Opioid-Dependent Patients: A Double Blind, Randomized Clinical Trial.

Ahmadi J, Sefidfard Jahromi M.

Subst Use Misuse. 2017 Nov 17:1-4. doi: 10.1080/10826084.2017.1400063.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29148881

Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.

Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH.

J Sex Med. 2017 Dec 20. pii: S1743-6095(17)31853-2. doi: 10.1016/j.jsxm.2017.12.004.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29275046

The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis.

Litz M, Leslie D.

Am J Addict. 2017 Dec;26(8):859-863. doi: 10.1111/ajad.12644. Epub 2017 Nov 16.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29143483

Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.

Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH.

J Sex Med. 2017 Dec 20. pii: S1743-6095(17)31853-2. doi: 10.1016/j.jsxm.2017.12.004.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29275046